Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Usefulness of Presepsin as Early Detective Marker of Sepsis in Immunodeficiency ICU Patients

NCT03881566 is registered in ClinicalTrials.gov with Jongmin Lee as lead sponsor.

NCT NCT03881566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03881566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Usefulness of Presepsin as Early Detective Marker of Sepsis in Immunodeficiency ICU Patients
Lead sponsor
Jongmin Lee
Phase
Observational
Overall status
Completed
Start date
March 1, 2019
Completion date
December 31, 2020
Enrollment
119 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune deficiency, sepsis